Matthew Roberts

Matthew Roberts

Company: GSK

Job title: Director, Cell & Gene Therapy Analytical Development


From Early to Late Phase: the Evolution of an Autologous Cell and Gene Therapy Potency Assay 12:00 pm

Technical aspects of autologous ex vivo CGT potency assays A case study of a CGT potency assay evolving from early to late-stage development Backdrop of regulatory and phase-appropriate considerations driving the evolution of the assay toward late stage developmentRead more

day: Track A - Day 2 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.